Navigation Links
Verenium to Present at Jefferies 11th Global Clean Technology Conference
Date:2/16/2011

a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, risks associated with Verenium's technologies, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operates and sells products, Verenium's dependence on manufacturing and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, and risks and other uncertainties more fully described in Verenium's filings with the Securities and Exchange Commission, including, but not limited to, Verenium's annual report on Form 10-K for the year ended December 31, 2009 and any upda
'/>"/>
SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
2. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
3. Verenium Reports Financial Results for the Third Quarter 2010
4. Verenium to Present at Jefferies 10th Global Clean Technology Conference
5. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
6. Verenium Announces Regulatory Approval for Purifine® PLC in China
7. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
8. Verenium Appoints Kevin Bracken Vice President of Manufacturing
9. Verenium Announces Proposed Public Offering of Common Stock
10. Verenium 1:12 Reverse Stock Split Takes Effect
11. Verenium Announces Reverse Stock Split to Take Effect September 9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014  Spherix Incorporated (Nasdaq: SPEX) -- an intellectual ... monetization of intellectual property, announced today that the ... Uniden in the U.S. District Court for the ... has been rescheduled for November 10, 2014.  This ... The Court Order setting the Markman date was ...
(Date:10/1/2014)... 2014 As the world takes its first ... doubt that this century would mark the beginning of a ... medicine science. The fact that the world is experiencing a ... the scientific community. Almost half of these chronic conditions are ... prevented with medical care and intervention. While the world is ...
(Date:10/1/2014)... (PRWEB) September 30, 2014 Today ... initial round of grants for the Brain Research ... that aims to develop and revolutionize new methods ... of the human brain. This first round of ... year 2014 was allocated to more than 100 ...
(Date:10/1/2014)... 30, 2014 New applications of structures ... have evolved in nature over millennia are featured in ... for applications in biophotonics in the October issue ... journal is published by SPIE, the international society for ... of the peer-reviewed articles are accessible via open access. ...
Breaking Biology Technology:Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 2Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 3NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3
... new microelectromechanical systems (MEMS) can benefit from a new ... and Technology (NIST) to measure a key mechanical property ... Youngs modulus of thin films not only for MEMS ... , Since 1727, scientists and engineers have used Youngs ...
... to high quality, fully annotated serum, tissue and blood ... available for Genomic ... Oncology Metrics, a,business that develops products and services ... Cureline Inc., a global,biosample management company dedicated to innovation ...
... 9 Novo Nordisk, a,healthcare company with an ... today announced the appointment of Alan C. Moses, ... is currently the,chief medical officer of Novo Nordisk ... the unique talent to integrate the science of ...
Cached Biology Technology:NIST develops test method for key micromechanical property 2Oncology Metrics and Cureline Announce Joint Marketing Agreement 2Oncology Metrics and Cureline Announce Joint Marketing Agreement 3Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide 2
(Date:9/30/2014)... to tetrachloroethylene (PCE) in drinking water may increase ... to a new study led by a Boston ... study, published in the journal Environmental Health ... pregnancies among 1,766 women in Cape Cod, Ma., ... to the early 1980s by the installation of ...
(Date:9/30/2014)... Fish can live in almost any aquatic environment on ... up many species are pushed to the limit. The ... could prove critical for how different species cope in ... the University of Gothenburg, published in the scientific journal ... Climate change continues apace thanks to increasing levels of ...
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
Breaking Biology News(10 mins):Contaminated water linked to pregnancy complications, BU study finds 2Shape up quickly -- applies to fish, too! 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... world will gather March 20-22 at the University of ... change for global agriculture and recommend science-based actions to ... food, livelihood and sustainability. The Climate-Smart Agriculture Global ... builds on a 2011 international meeting on this theme ...
... SAN FRANCISCO Heart patients who can,t tolerate the ... option, according to a new study by researchers from ... Salt Lake City. Researchers found that pitavastatin, a ... attack, stroke and even death in up to 68 ...
... competition the Museum of Evolution at Uppsala University, Sweden, has ... Thunberg collection. The project will make the valuable plants available ... 350 years since Linnaeus,s disciple Carl Thunberg travelled with the ... Lanka and Java. In total he collected almost 28,000 plants ...
Cached Biology News:International conference to tackle climate-change threats to agriculture 2Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins 2Carl Thunberg's Japanese plants to be digitized 2
... Assay, 96 wells. ELISA.Specific for total ... MMP-3. No cross-reactivity with MMP-1, -2, -9. ... use with cell culture supernatant, serum, plasma ... to -30 C. Category: Drug Screening ...
... Dr. P Set from different human ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Biology Products: